Tianfu Wu

Dr. Tianfu Wu

University of Houston, Houston, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2016 in ACS Nano
Verified
Journal Article
Closed access
JHJian-Fei Huang
Jian-Fei Huang
JZJing Zhong
Jing Zhong
GCGuo-Pu Chen
Guo-Pu Chen
Zuantao LinZuantao Lin
Zuantao Lin
YDYuqing Deng
Yuqing Deng
GJGang-Biao Jiang
Gang-Biao Jiang

1 December 2005 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
QZQuan Li Zhen
Quan Li Zhen
CXChun Xie
Chun Xie
Tianfu WuTianfu Wu
Tianfu Wu
MMMeggan Mackay
Meggan Mackay
CACynthia Aranow
Cynthia Aranow
CMChandra Mohan
Chandra Mohan
Nephrophilic autoantibodies dominate the seroprofile in lupus, but their fine specificities remain ill defined. We constructed a multiplexed proteome microarray bearing about 30 antigens known to be expressed in the glomerular milieu and used it to study serum autoantibodies in lupus. Compared with normal serum, serum from B6.Sle1.lpr lupus mice (C57BL/6 mice homozygous for the NZM2410/NZW allele of Sle1 as well as the FASlpr defect) exhibited high levels of IgG and IgM antiglomerular as well as anti–double-stranded DNA/chromatin Abs and variable levels of Abs to α-actinin, aggrecan, collagen, entactin, fibrinogen, hemocyanin, heparan sulphate, laminin, myosin, proteoglycans, and histones. The use of these glomerular proteome arrays also revealed 5 distinct clusters of IgG autoreactivity in the sera of lupus patients. Whereas 2 of these IgG reactivity clusters (DNA/chromatin/glomeruli and laminin/myosin/Matrigel/vimentin/heparan sulphate) showed association with disease activity, the other 3 reactivity clusters (histones, vitronectin/collagen/chondroitin sulphate, and entactin/fibrinogen/hyaluronic acid) did not. Human lupus sera also displayed 2 distinct IgM autoantibody clusters, one reactive to DNA and the other apparently polyreactive. Interestingly, the presence of IgM polyreactivity in patient sera was associated with reduced disease severity. Hence, the glomerular proteome array promises to be a powerful analytical tool for uncovering novel autoantibody disease associations and for distinguishing patients at high risk for end-organ disease.

19 June 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Tianfu WuTianfu Wu
Tianfu Wu
CXChun Xie
Chun Xie
JHJie Han
Jie Han
YYYujin Ye
Yujin Ye
JWJim Weiel
Jim Weiel
CMChandra Mohan
Chandra Mohan
The metabolic disturbances that underlie systemic lupus erythematosus are currently unknown. A metabolomic study was executed, comparing the sera of 20 SLE patients against that of healthy controls, using LC/MS and GC/MS platforms. Validation of key differences was performed using an independent cohort of 38 SLE patients and orthogonal assays. SLE sera showed evidence of profoundly dampened glycolysis, Krebs cycle, fatty acid β oxidation and amino acid metabolism, alluding to reduced energy biogenesis from all sources. Whereas long-chain fatty acids, including the n3 and n6 essential fatty acids, were significantly reduced, medium chain fatty acids and serum free fatty acids were elevated. The SLE metabolome exhibited profound lipid peroxidation, reflective of oxidative damage. Deficiencies were noted in the cellular anti-oxidant, glutathione, and all methyl group donors, including cysteine, methionine, and choline, as well as phosphocholines. The best discriminators of SLE included elevated lipid peroxidation products, MDA, gamma-glutamyl peptides, GGT, leukotriene B4 and 5-HETE. Importantly, similar elevations were not observed in another chronic inflammatory autoimmune disease, rheumatoid arthritis. To sum, comprehensive profiling of the SLE metabolome reveals evidence of heightened oxidative stress, inflammation, reduced energy generation, altered lipid profiles and a pro-thrombotic state. Resetting the SLE metabolome, either by targeting selected molecules or by supplementing the diet with essential fatty acids, vitamins and methyl group donors offers novel opportunities for disease modulation in this disabling systemic autoimmune ailment.

1 June 2010 in Journal of Autoimmunity
Verified
Journal Article
Closed access
MSMarie-Laure Santiago-Raber
Marie-Laure Santiago-Raber
IDIsabelle Dunand-Sauthier
Isabelle Dunand-Sauthier
Tianfu WuTianfu Wu
Tianfu Wu
QLQuan-Zhen Li
Quan-Zhen Li
SUSatoshi Uematsu
Satoshi Uematsu
SIShozo Izui
Shozo Izui

1 February 2008 in Immunity
Verified
Journal Article
Closed access
JHJack Hutcheson
Jack Hutcheson
JSJohn C. Scatizzi
John C. Scatizzi
ASAkbar M. Siddiqui
Akbar M. Siddiqui
GHG. Kenneth Haines
G. Kenneth Haines
Tianfu WuTianfu Wu
Tianfu Wu
HPHarris Perlman
Harris Perlman

24 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAmy M. Becker
Amy M. Becker
KDKathryn H. Dao
Kathryn H. Dao
BHBobby Kwanghoon Han
Bobby Kwanghoon Han
RKRoger Kornu
Roger Kornu
SLShuchi Lakhanpal
Shuchi Lakhanpal
LDLaurie S. Davis
Laurie S. Davis
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is characterized by defective immune tolerance combined with immune cell hyperactivity resulting in the production of pathogenic autoantibodies. Previous gene expression studies employing whole blood or peripheral blood mononuclear cells (PBMC) have demonstrated that a majority of patients with active disease have increased expression of type I interferon (IFN) inducible transcripts known as the IFN signature. The goal of the current study was to assess the gene expression profiles of isolated leukocyte subsets obtained from SLE patients. Subsets including CD19+ B lymphocytes, CD3+CD4+ T lymphocytes and CD33+ myeloid cells were simultaneously sorted from PBMC. The SLE transcriptomes were assessed for differentially expressed genes as compared to healthy controls. SLE CD33+ myeloid cells exhibited the greatest number of differentially expressed genes at 208 transcripts, SLE B cells expressed 174 transcripts and SLE CD3+CD4+ T cells expressed 92 transcripts. Only 4.4% (21) of the 474 total transcripts, many associated with the IFN signature, were shared by all three subsets. Transcriptional profiles translated into increased protein expression for CD38, CD63, CD107a and CD169. Moreover, these studies demonstrated that both SLE lymphoid and myeloid subsets expressed elevated transcripts for cytosolic RNA and DNA sensors and downstream effectors mediating IFN and cytokine production. Prolonged upregulation of nucleic acid sensing pathways could modulate immune effector functions and initiate or contribute to the systemic inflammation observed in SLE.